News

Explore This Section

UCLA Researchers Currently Developing Rapid COVID-19 Testing

UCLA researchers in the Department of Molecular and Medical Pharmacology have discovered high affinity binding affibodies to COVID-19’s nucleocapsid protein that provide the basis for an ELISA-based diagnostic platform. The researchers are currently developing affibody-coated test strips for saliva detection of COVID-19 in high population settings or at home testing. More information can be found here

 

 

In Vivo Feature: How Proximity Creates Partnerships

How Proximity Creates Partnerships
VC Playbook: Sean Harper’s Bet On A Rising City Of Angels

21 Oct 2019 INTERVIEWS
by William Looney @BillInVivo william.looney@informa.com
Executive Summary

Former Amgen R&D lead Sean Harper talks exclusively to In Vivo about his new role as a venture capitalist, joining veteran industry investor Beth Seidenberg as co-founder of Los Angeles-based Westlake Village BioPartners.

Reprinted with permission from 

2020 Application Faculty Innovation Fund Open

We are happy to announce an open call for UCLA’s second cohort of Faculty Innovation Fellows (FIF). Started by the Technology Development Group, the Office of Research and Creative Activities, and Startup UCLA, the Faculty Innovation Fellows is a program aimed at advancing entrepreneurial excellence and startup culture among faculty across campus. A UCLA Newsroom story about last year’s program can be found here.

BRAINBox Announces Allowance of Patent on Novel TBI Biomarkers

U.S. Patent Office to Issue Patent for Detecting Traumatic Brain Injury (TBI) Using Aldolase C

The Notice of Allowance issued by the PTO to The Regents of the University of California through UCLA
Technology Development Group indicates that another U.S. patent, exclusively licensed to BRAINBox
Solutions, will be issued to protect the biomarker panels to be used by BRAINBox Solutions in its pointof-
care products that detect TBI and monitor patient recovery. BRAINBox Solutions previously obtained